PD-1 treatment may help by shifting certain immune cells to fight diseases like kidney cancer; higher CD163-positive TAMs are linked to better outcomes.

Lafayette resident and Stage IV cancer patient Keith Hollingsworth is lucky to be here. Others in the near future may not be so fortunate.